EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Comparison of Interferon‐Based and Interferon‐Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus‐Sustained Virological Response: A Multicenter Study

Shinji Itoh iD, Norifumi Iseda, Tomoharu Yoshizumi, Takao Ide, Hirokazu Noshiro, Hisamune Sakai, Toru Hisaka, Masao Nakashima, Hiroaki Nagano iD, Hirohisa Okabe iD, Hiromitsu Hayashi iD, Atsushi Miyoshi und 11 weitere

Cancer Medicine · 2026-06 · 15 (6)

DOI: 10.1002/cam4.71963 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 11.06.2026. Verfasst von Shinji Itoh und 22 weiteren Autor:innen. Beteiligte Einrichtung: Kyushu Study Group of Liver Surgery, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antiviral Agents, Interferons. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

We examine the impact of interferon (IFN)‐based and IFN‐free treatment on the prognosis of hepatocellular carcinoma (HCC) after hepatitis C virus (HCV) sustained virological response (SVR).

Methods

Clinical information was collected on 311 cases of HCC after HCV‐SVR from 16 facilities affiliated with the Kyushu Liver Surgery Study Group. Clinical factors and the tumor microenvironment of HCC after SVR treatment with IFN‐based and IFN‐free treatments were analyzed.

Results

No statistically significant differences were observed in the recurrence rate and overall survival (OS) between the two groups. Propensity score–matched analysis similarly showed no statistically significant differences in recurrence and OS. In the IFN‐based treatment group, OS time was significantly shorter for the programmed death‐ligand 1(PD‐L1)‐positive HCC than the PD‐L1‐negative HCC group ( p = 0.0183). No significant difference was observed in the recurrence rate between PD‐L1‐positive and PD‐L1‐negative HCC groups. In the IFN‐based treatment group, the recurrence rate in the cluster of differentiation (CD) 8‐positive group was significantly lower than in the CD8‐negative group ( p = 0.0292). There was no difference in OS time between the CD8‐positive and CD8‐negative groups. In the IFN‐free treatment group, PD‐L1 and CD8 were not associated with recurrence rate or OS.

Conclusions

No statistically significant differences were observed in recurrence or OS rate after HCC resection in the IFN‐free treatment group compared with the IFN‐based treatment group. In the IFN‐based treatment group, PD‐L1 and CD8 expression on cancer cells might be prognostic factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntiviral AgentsInterferonsHumansPrognosisFemaleMaleHepacivirusSustained Virologic ResponseMiddle AgedNeoplasm Recurrence, LocalTumor MicroenvironmentB7-H1 Antigen

Stichwörter der Autor:innen

direct‐acting antiviralshepatitis C virushepatocellular carcinomainterferonsustained virological response

Substanzen

Antiviral AgentsInterferonsB7-H1 Antigen

Autor:innen und Institutionen

  • Kyushu Study Group of Liver Surgery, Japan.
  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Surgery, Saga University Faculty of Medicine, Saga, Japan.
  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Kurume University, Kurume, Japan.
  • Department of Gastroenterological, Breast, and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.

ORCID-Profile: Shinji Itoh, Hiroaki Nagano, Hirohisa Okabe, Hiromitsu Hayashi, Atsushi Nanashima, Toru Beppu

Zitieren

APA

Itoh, S., Iseda, N., Yoshizumi, T., Ide, T., Noshiro, H., Sakai, H., Hisaka, T., Nakashima, M., Nagano, H., Okabe, H., Hayashi, H., Miyoshi, A., Kitahara, K., Takami, Y., Nanashima, A., Kuroki, T., Endo, Y., Okamoto, K., Kajiwara, M., …, & Eguchi, S. (2026). Comparison of Interferon‐Based and Interferon‐Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus‐Sustained Virological Response: A Multicenter Study. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71963

Vancouver

Itoh S, Iseda N, Yoshizumi T, Ide T, Noshiro H, Sakai H, et al. Comparison of Interferon‐Based and Interferon‐Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus‐Sustained Virological Response: A Multicenter Study. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71963

BibTeX
@article{Itoh2026,
  author = {Itoh, Shinji and Iseda, Norifumi and Yoshizumi, Tomoharu and Ide, Takao and Noshiro, Hirokazu and Sakai, Hisamune and Hisaka, Toru and Nakashima, Masao and Nagano, Hiroaki and Okabe, Hirohisa and Hayashi, Hiromitsu and Miyoshi, Atsushi and Kitahara, Kenji and Takami, Yuko and Nanashima, Atsushi and Kuroki, Tamotsu and Endo, Yuichi and Okamoto, Kohji and Kajiwara, Masatoshi and Sakoda, Masahiko and Beppu, Toru and Takatsuki, Mitsuhisa and Eguchi, Susumu},
  title = {Comparison of Interferon‐Based and Interferon‐Free Treatments on the Prognosis of Hepatocellular Carcinoma After Hepatitis C Virus‐Sustained Virological Response: A Multicenter Study},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cam4.71963}
}
Kostenlos starten →